Cresco Labs Cleared to Open Downtown Chicago Cannabis Dispensary

Cresco Labs Granted Final State Approval to Open the First Adult-use Dispensary in Downtown Chicago

Sunnyside River North will open soon for online sales

CHICAGO, April 06, 2020-(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it received an adult-use dispensing organization license from the Illinois Department of Financial Regulation for its dispensary located at 436 N. Clark Street in the prestigious River North neighborhood of Chicago. Sunnyside River North (the “Dispensary”) will soon begin adult-use cannabis sales online for pick up through a pop-up retail experience. As part of the procedures they’ve implemented system-wide to eliminate wait lines, crowding and follow social distancing guidelines during the COVID-19 pandemic, the Dispensary will operate with online orders only through Once customers receive a notification that their order is ready, they can visit the store at staggered times for order pick up. Normal store hours will be 10:00 AM to 9:00 PM daily, seven days a week.

The Dispensary is located in the former home of the iconic Baton Club, right at the heart of one of the most dynamic downtown neighborhoods of Chicago. River North is home to hotels, restaurants, a variety of nightlife options as well as residential buildings, offering retailers in the area consistent foot traffic day and night. The area touches the Loop and the Magnificent Mile on North Michigan Avenue, which is Chicago’s premier commercial district and a destination point for Chicago’s 58 million visitors annually1. As the first recreational only cannabis store to open in the city, Cresco’s River North location will be ideally positioned to act as both a driver of retail results as well as a brand showcase for the Company.

We are thrilled to make history in our home city, opening Chicago’s first-ever recreational only dispensary in such a sought-after location. The state’s approval provides a significant opportunity for Cresco to grow its retail footprint and serve more consumers across the state through six Sunnyside dispensaries—two of which are in Chicago.

Charlie Bachtell, Cresco Labs CEO and Co-founder

It is also incredibly rewarding to be able to help the local community during such a challenging and uncertain time by providing more convenient access to downtown residents, adding new jobs, and acting as a good community partner to build impactful, positive relationships with local businesses and provide essential products and other support that our community members need.

Mr. Bachtell added, “The Illinois adult-use market is proving to be as robust as forecasted with nearly $110 million in sales during the first three months2 of 2020 and approximately $188 million including adult and medical sales. With our strategic retail footprint and our expanding cultivation footprint, I am confident that Cresco is well-positioned to be a long-term leader in the Illinois market.”

As previously announced, the Dispensary is one of two licenses that Cresco won in the Central Business District in the city of Chicago’s lottery. Sunnyside River North is the Company’s sixth retail location in Illinois. Cresco also has licenses to open an additional four dispensaries and has so far announced its intention to open locations in the Gold Coast neighborhood of Chicago, as well as Danville, Schaumburg and South Beloit in Illinois.

Illinois is expected to be a $2 – $4 billion dollar market at maturity3. To strengthen its leading market share in the Illinois market, Cresco is nearing completion of a significant expansion that will bring total cultivation to 243,000 square feet and will considerably increase supply to support its dispensaries and wholesale distribution across the state. Cresco is able to expand its three cultivation facilities to an aggregate total of 630,000 sq. ft. of flowering canopy—the largest capacity footprint allowed in the state4. Cresco currently sells into 100% of licensed dispensaries in Illinois and has maintained its leading market share of wholesale sales in the state.

About Cresco Labs:

Cresco Labs is one of the largest vertically-integrated multi-state cannabis operators in the United States. Cresco is built to become the most important company in the cannabis industry by combining the most strategic geographic footprint with one of the leading distribution platforms in North America. Employing a consumer-packaged goods (“CPG”) approach to cannabis, Cresco’s house of brands is designed to meet the needs of all consumer segments and includes some of the most recognized and trusted national brands including Cresco, Remedi and Mindy’s, a line of edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside*, Cresco’s national dispensary brand, is a wellness-focused retailer designed to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco has launched the industry’s first national comprehensive Social Equity and Educational Development (SEED) initiative designed to ensure that all members of society have the skills, knowledge and opportunity to work in and own businesses in the cannabis industry. Learn more about Cresco Labs at

1 Choose Chicago Tourism Bureau
3 Illinois is projected to be a $2-4 billion dollar market at maturity according to Marijuana Business Daily making it one of largest cannabis markets in US.
4 State of Illinois, Department of Agriculture cannabis cultivation licenses

Original Press Release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter